Publications:

Construction and validation of safe Clostridium botulinum Group II surrogate strain producing inactive botulinum neurotoxin type E toxoid.

Scientific Reports

Nowakowska, Maria B MB; Selby, Katja K; Przykopanski, Adina A; Krüger, Maren M; Krez, Nadja N; Dorner, Brigitte G BG; Dorner, Martin B MB; Jin, Rongsheng R; Minton, Nigel P NP; Rummel, Andreas A; Lindström, Miia M

Publication Date: 2022-02-02

Variant appearance in text: 225: R348A

PubMed Link: 35110559

Variant Present in the following documents:

• Main text
• 41598_2022_Article_5008.pdf

View BVdb publication page

Construction and validation of safe Clostridium botulinum Group II surrogate strain producing inactive botulinum neurotoxin type E toxoid.

Scientific Reports

Nowakowska, Maria B MB; Selby, Katja K; Przykopanski, Adina A; Krüger, Maren M; Krez, Nadja N; Dorner, Brigitte G BG; Dorner, Martin B MB; Jin, Rongsheng R; Minton, Nigel P NP; Rummel, Andreas A; Lindström, Miia M

Publication Date: 2022-02-02

Variant appearance in text: 225: R348A

PubMed Link: 35110559

Variant Present in the following documents:

• Main text
• 41598_2022_Article_5008.pdf

View BVdb publication page

Structure-based mechanism for activation of the AAA+ GTPase McrB by the endonuclease McrC.

Nature Communications

Nirwan, Neha N; Itoh, Yuzuru Y; Singh, Pratima P; Bandyopadhyay, Sutirtha S; Vinothkumar, Kutti R KR; Amunts, Alexey A; Saikrishnan, Kayarat K

Publication Date: 2019-07-11

Variant appearance in text: 225: R348A

PubMed Link: 31296862

Variant Present in the following documents:

• Main text
• 41467_2019_Article_11084.pdf

View BVdb publication page